Newsroom | 191264 results
Sorted by: Latest
-
Rigaku和SPERA PHARMA建立战略合作伙伴关系共同推进药物开发
东京--(BUSINESS WIRE)--(美国商业资讯)-- Rigaku Holdings Corporation旗下子公司Rigaku Corporation(总部:东京昭岛市;首席执行官:Jun Kawakami;以下简称“Rigaku”),与SPERA PHARMA, Inc.(总部:大阪市;董事长兼代表董事:Keitaro Iwaki;以下简称“SPERA PHARMA”)宣布达成战略合作,旨在通过整合双方尖端技术与深厚专业知识,加速并革新药物研发进程。 SPERA PHARMA将采用Rigaku提供的电子衍射集成平台XtaLAB Synergy-ED开展合约分析服务,为客户的药物研发提供强力支持。 XtaLAB Synergy-ED搭载的3D ED/MicroED1可用于物质结构分析,包括显微晶体和微量结晶粉末。这项尖端技术具有足够高的分辨率,可以确定原子级结构,实现有机化合物和类似物质分子结构的精密阐明。 SPERA PHARMA目前是全球医药行业唯一一家提供XtaLAB Synergy-ED合约分析服务的企业。Rigaku将为SPERA PHARMA的合约分析业务提供...
-
Aptar Declares Quarterly Dividend
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend...
-
Performant Survey Spotlights Top Healthcare Technology Initiatives
PLANTATION, Fla.--(BUSINESS WIRE)--At HIMSS25, Performant Healthcare, Inc. (Nasdaq: PHLT) (the “Company” or “Performant”), a leader in technology-enabled payment integrity, eligibility and related analytics services, conducted a targeted survey of nearly 150 healthcare technology leaders to better understand the key drivers behind healthcare technology decision-making. The findings point to a healthcare landscape increasingly shaped by innovation, efficiency and the imperative to deliver better...
-
Riassunto: Rigaku e SPERA PHARMA avviano una partnership strategica per uno sviluppo farmaceutico avanzato
TOKYO--(BUSINESS WIRE)--Rigaku Corporation, azienda del Gruppo di Rigaku Holdings Corporation (sede centrale: Akishima, Tokyo; CEO: Jun Kawakami; di seguito “Rigaku”), e SPERA PHARMA, Inc. (sede centrale: Osaka; Presidente e Direttore rappresentante: Keitaro Iwaki; di seguito “SPERA PHARMA”) hanno avviato una collaborazione strategica mirata ad accelerare e trasformare uno sviluppo farmaceutico utilizzando le tecnologie all'avanguardia e le vaste competenze delle due aziende. SPERA PHARMA utili...
-
Rigaku y SPERA PHARMA: una asociación estratégica para el desarrollo farmacéutico avanzado
TOKIO--(BUSINESS WIRE)--Rigaku Corporation, empresa del grupo Rigaku Holdings Corporation (sede central: Akishima, Tokio; gerente general: Jun Kawakami; en adelante, ''Rigaku''), y SPERA PHARMA, Inc. (sede central: Osaka; presidente y director representante: Keitaro Iwaki; en adelante, ''SPERA PHARMA'') iniciaron una asociación estratégica destinada a acelerar y transformar el desarrollo farmacéutico, aprovechando las tecnologías de vanguardia y la vasta experiencia de ambas empresas. XtaLAB Sy...
-
Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2025, on May 7, 2025, and host a webcast and conference call on May 8, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. May 8, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast...
-
FIGS Announces Date of First Quarter 2025 Earnings Release, Conference Call and Webcast
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a first quarter 2025 fin...
-
Warby Parker to Announce First Quarter 2025 Financial Results on May 8, 2025
NEW YORK--(BUSINESS WIRE)--Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2025 will be released before market open on May 8, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-9...
-
Butterfly Network to Report First Quarter 2025 Financial Results on May 2, 2025
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report first quarter 2025 financial results on May 2, 2025 before the market opens. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will...
-
GE HealthCare to announce first quarter 2025 results on April 30, 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its first quarter 2025 financial results before the market opens on Wednesday, April 30, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will...